The U.S. Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract to Quest Diagnostics Incorporated, a provider of diagnostic information services, for a "Test Surge and Data Sharing" program. The $493,118 contract has a period of performance through September 2025 and is a time and materials type contract. This IDIQ vehicle allows the CDC to procure clinical laboratory testing and analysis services from Quest Diagnostics on an...
This is a federal contract award to Quest Diagnostics Incorporated, doing business as Quest Diagnostics, by the Centers for Disease Control and Prevention (CDC) for a Test Surge and Data Sharing Multiple Award Indefinite Delivery Indefinite Quantity (IDIQ) contract. The contract has a ceiling value of $3,636,702.00 and an ultimate completion date of September 26, 2029. The contract is for delivery orders and is a Firm Fixed Price type. The contract does not have a set-aside designation. Quest...
This is a $4,470,182.84 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, a provider of diagnostic information services. The contract is for "QUEST DIAGNOSTICS DATA" and has a period of performance through March 3, 2025. Quest Diagnostics has previously provided COVID-19 and other infectious disease testing services, as well as reference laboratory testing support, to various federal agencies...
This is a $24,691,200 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated for serology testing services. The contract has a period of performance through March 5, 2022 and was awarded on November 13, 2020 without any set-aside designation. Quest Diagnostics, a for-profit diagnostic information services provider, has previously supported federal agencies such as the Department of Justice's Bureau of Prisons, the...
This is a $74,393,160.50 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, a large for-profit diagnostic information services provider. The contract is for COVID-19 genomic sequencing services and has a completion date of April 22, 2025. The contract is a firm-fixed-price type and does not utilize any set-aside designations. Quest Diagnostics has a strong track record of providing reference laboratory testing and diagnostic...
The Centers for Disease Control and Prevention (CDC) awarded a $14 million firm fixed price delivery order contract to Quest Diagnostics Incorporated for surge serology testing services. Under the contract, Quest Diagnostics will provide COVID-19 antibody testing from its laboratory located in Secaucus, New Jersey to support the CDC's pandemic response efforts. The period of performance is from July 30, 2020 through November 19, 2020. No set aside designation or subcontractors were identified....
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Clinical Laboratories, Inc., a subsidiary of Quest Diagnostics Incorporated, for $92,922.00 in laboratory services. The contract is for the provision of comprehensive diagnostic testing solutions, including drug and alcohol testing, COVID-19 testing, and specialized diagnostic analyses, to support various federal healthcare, law enforcement, and workplace safety...
This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Quest Diagnostics Incorporated, a for-profit diagnostic information services provider, for data submission services. The contract is a definitive, firm fixed-price contract with a potential value of $722,500.00. The purpose is to obtain laboratory test order and test result data, including longitudinal patient identifiers but without personally identifiable information, to...
The Centers for Disease Control and Prevention awarded a firm-fixed price contract valued at $1,676,070.04 to Quest Diagnostics Clinical Laboratories, Inc. to meet requirements established in a January 2020 solicitation. The solicitation sought longitudinal laboratory test order and result data for hosting in CDC's Data Hub to support analyses of public health trends related to reportable diseases and exposures over time. Only Quest could fulfill this requirement due to its market share and...
This is a $325,072 delivery order awarded to Quest Diagnostics Incorporated by the Centers for Disease Control and Prevention (CDC) for H5N1 test development services. The order was issued under the Test Surge and Data Sharing indefinite delivery, indefinite quantity (IDIQ) contract, which provides a vehicle for the CDC to procure specialized clinical laboratory testing and analysis on an as-needed basis. Quest Diagnostics is a for-profit organization that has provided laboratory testing...